TY  - BOOK
AU  - Boyce, Steven W
TI  - Hybrid Exclusion of HeartMate II Left Ventricular Assist Device After Bridge to Recovery
SN  - 0003-4975
PY  - 2016///
KW  - *Cardiomyopathy, Dilated/th [Therapy]
KW  - *Heart-Assist Devices
KW  - *Myocarditis/th [Therapy]
KW  - *Septal Occluder Device
KW  - Adolescent
KW  - Antibiotics, Antineoplastic/ae [Adverse Effects]
KW  - Bone Neoplasms/dt [Drug Therapy]
KW  - Bone Neoplasms/su [Surgery]
KW  - Cardiomyopathy, Dilated/ci [Chemically Induced]
KW  - Device Removal/ct [Contraindications]
KW  - Female
KW  - Heart Failure/et [Etiology]
KW  - Humans
KW  - Osteosarcoma/dt [Drug Therapy]
KW  - Osteosarcoma/su [Surgery]
KW  - Postoperative Complications/et [Etiology]
KW  - Postoperative Complications/th [Therapy]
KW  - Shock, Cardiogenic/et [Etiology]
KW  - Shock, Cardiogenic/th [Therapy]
KW  - Unnecessary Procedures
KW  - MedStar Heart & Vascular Institute
KW  - Journal Article
N1  - Available online from MWHC library: 1995 - present, Available in print through MWHC library:1999-2007
N2  - Copyright � 2016 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved; We present a hybrid technique of left ventricular assist device exclusion after bridge to recovery in a pediatric patient, using percutaneous occlusion of the outflow graft and surgical excision of driveline. This technique has the advantage of avoiding chest reentry and cardiopulmonary bypass.
UR  - https://dx.doi.org/10.1016/j.athoracsur.2015.10.040
ER  -